CHICAGO – NorthShore University HealthSystem has wrapped up its DNA-10K pilot to integrate genetic testing into primary care, and the five-hospital system is looking to expand testing to more clinics, in partnership with genetic testing firm Color and molecular clinical decision support technology vendor ActX.
Notably, the program demonstrated success in identifying patients at elevated risk for hereditary cancer and cardiovascular disease, as well as for enabling pharmacogenomics at population scale.